Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
11don MSN
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Ozempic is the newest craze to take ... the billionaire tweeted on Oct. 1, 2022, “Fasting” and “Wegovy.” Oprah Winfrey did not specify which weight-loss drug she uses.
Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback